1. Articles from Notal Vision

    1-4 of 4
    1. AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics

      AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics

      Longitudinal data on retinal imaging of age-related macular degeneration (AMD) patients using the final form factor of Notal Vision’s home OCT (NOTAL-OCT V3.0) was presented at the Angiogenesis, Exudation, and Degeneration meeting in Miami. The pipeline technology is designed to use home-based, patient-initiated retinal OCT scans to support the management of patients with exudative AMD, complementing existing standard of care as well as emerging longer acting drugs and drug delivery systems. “This is the first time nano-liter scale quantities of intra- and subretinal fluid have been tracked over time based on home OCT images and deep learning retinal ...

      Read Full Article
    2. CPT codes for home OCT established

      CPT codes for home OCT established

      The AMA’s CPT® Editorial Panel has accepted three new category III codes for reporting patient-initiated remote retinal OCT scans, facilitated by Notal Vision’s home-based OCT pipeline technology Notal Vision, Inc., a privately held ophthalmic diagnostic services company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, announced today that the American Medical Association’s (AMA) Current Procedural Terminology (CPT) Editorial Panel has established three new Category III codes (0604T, 0605T, 0606T) to report patient-initiated remote retinal optical coherence tomography (OCT) scans, which is performed using Notal Vision’s home-based ...

      Read Full Article
    3. Notal Vision Announces Appointment of Dr. Kester Nahen as Chief Executive Officer

      Notal Vision Announces Appointment of Dr. Kester Nahen as Chief Executive Officer

      Notal Vision, Ltd., a privately held ophthalmic company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, is pleased to announce the appointment of Kester Nahen, PhD as Chief Executive Officer. Dr. Nahen joined the company as Chief Commercial Officer in August 2019, bringing a wealth of global leadership experience in the medical device industry to his new position. "I am delighted that Kester Nahen has accepted the offer to be Chief Executive Officer and lead Notal Vision through the company's next phase of growth and beyond," said Guy Katsav ...

      Read Full Article
    4. Dr. Kester Nahen joins Notal Vision as Chief Commercial Officer

      Dr. Kester Nahen joins Notal Vision as Chief Commercial Officer

      Notal Vision, Inc., a company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, is pleased to announce the appointment of Kester Nahen, PhD to Chief Commercial Officer. Dr. Nahen is a medical device industry expert and brings more than 18 years of well-rounded international business experience in product management, medical science, clinical research, marketing, sales, professional education, and business development to the company. "I am delighted to welcome Kester to the Notal Vision executive team,” stated Dr. Susan Orr, Chief Executive Officer of Notal Vision. “I am confident that his ...

      Read Full Article
    1-4 of 4
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics in the News

    1. (4 articles) Kester Nahen
    2. (4 articles) Notal Vision
    3. (2 articles) University of Lübeck
    4. (2 articles) Susan Orr
    5. (2 articles) Heidelberg Spectralis
    6. (1 articles) FDA
    7. (1 articles) Harvard University
    8. (1 articles) Massachusetts General Hospital
    9. (1 articles) University College London
    10. (1 articles) Masamichi Takano
    11. (1 articles) Tsunenari Soeda
    12. (1 articles) Ik-Kyung Jang
    13. (1 articles) Pearse A. Keane
    14. (1 articles) Hang Lee
    15. (1 articles) Kyoichi Mizuno
    16. (1 articles) Zeiss Cirrus HD-OCT
  3. Popular Articles

  4. Picture Gallery

    Dr. Kester Nahen joins Notal Vision as Chief Commercial Officer Notal Vision Announces Appointment of Dr. Kester Nahen as Chief Executive Officer CPT codes for home OCT established AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics Reversible retinoschisis following high voltage electrical injury evaluated with optical coherence tomography and electrophysiology Measurement of optic axis orientation with single-mode fiber-based polarization-sensitive optical coherence tomography Investigating Local Polarisation Contrast With Fibre-Based Polarisation-Sensitive Optical Coherence Tomography and Microscopy (Thesis) Fundus fluorescein angiography and optical coherence tomography findings in ocular and non-ocular Behҫet’s disease Optical Coherence Tomography as a Diagnostic Adjunct for Ocular Surface Lesions The impact of therapeutic mediastinal radiation on stent healing in cancer patients: An optical coherence tomography study. Optical Coherence Tomography and Its Non-medical Applications (Textbook) Deep learning architectures analysis for age-related macular degeneration segmentation on optical coherence tomography scans